Primo, Topical Anesthetic gel, Benzocaine 20%, Net Content: 1 oz. (30g), Gluten Free, Manufacture...

FDA Drug Recall #D-0139-2025 — Class II — November 14, 2024

Recall Summary

Recall Number D-0139-2025
Classification Class II — Moderate risk
Date Initiated November 14, 2024
Status Completed
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Keystone Industries
Location Gibbstown, NJ
Product Type Drugs

Product Description

Primo, Topical Anesthetic gel, Benzocaine 20%, Net Content: 1 oz. (30g), Gluten Free, Manufactured for: Primo Dental Products, 845 Third Avenue, 6th Floor, New York, NY 10022.

Reason for Recall

CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing vessel. Product was to be rejected but was inadvertently released and shipped to customers.

Distribution Pattern

Nationwide in the USA and Canada, Dominican Republic, El Salvador, Honduras, and Qatar.

Lot / Code Information

Lot: BNZ-001646, Exp Date: 11/26/2026, Keystone Item No. 03-13119

Other Recalls from Keystone Industries

Recall # Classification Product Date
D-0147-2025 Class II Ipana, 20% Benzocaine Topical Gel, 28g, Maxill ... Nov 14, 2024
D-0137-2025 Class II Gelato, Benzocaine 20% Topical Gel Anesthetic G... Nov 14, 2024
D-0138-2025 Class II M&S Dental Supply Co LLC., Topical Anesthetic G... Nov 14, 2024
D-0144-2025 Class II Pearson Quality, Topical Anesthetic Gel, 20% Be... Nov 14, 2024
D-0143-2025 Class II Burkhart, Topical Anesthetic Gel, Benzocaine 20... Nov 14, 2024

Frequently Asked Questions

cGMP stands for Current Good Manufacturing Practice — the FDA's regulations governing drug manufacturing quality. A cGMP recall means the company failed to follow required manufacturing standards. This could involve inadequate testing, poor environmental controls, documentation failures, or process deviations. cGMP recalls do not always mean the product is directly harmful — in many cases, quality records are insufficient to confirm the product meets specifications. However, the FDA requires a recall because without proper documentation, product quality cannot be assured. These are often Class II or Class III recalls.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.